The Office of the Deputy Prime Minister and the Ministry of Health said in a statement that Malta has recorded its best-ever results in assisted reproductive services, with the highest national pregnancy rate and highest number of babies born through IVF registered to date, according to figures released by the Embryo Protection Authority (EPA).
The results were highlighted during a parliamentary debate on the Authority's financial estimates and annual report, where Deputy Prime Minister and Health Minister Ian Borg said continued government investment in assisted reproductive technology was leading to more successful treatments and helping more families achieve their dream of becoming parents.
Figures for 2025 show that the EPA received 2,049 applications for approval of Assisted Reproductive Technology (ART) procedures, with 774 IVF procedures carried out during the year.
These resulted in 249 pregnancies, producing a record national pregnancy rate of 57.77%, an increase of 11.47 percentage points compared with 2024.
A total of 254 babies were born through IVF in 2025, marking a new national record. The national Take Home Baby Rate also reached an all-time high of 45.01%.
The government said Malta's success rates now place the country among the leading European nations in assisted reproduction, with results significantly above European averages for both conventional IVF treatments and procedures involving donor sperm and donor oocytes.
Addressing Parliament, Borg said the results demonstrated that reforms and investment implemented in recent years were producing tangible outcomes.
"The success we are achieving in terms of statistics makes us proud and confirms that the investments made are bearing fruit, but ultimately we must never forget that behind every number there is a child, there is a family and there is a future," he said.
Borg also recalled that the government had introduced amendments to Malta's IVF legislation during the first 100 days of the previous legislature, including the introduction of Pre-Genetic Testing for Monogenic Diseases (PGTM).
He reiterated the government's commitment to expanding, within the first 100 days of the current legislature, the list of genetic conditions eligible for PGTM testing.
Borg said the latest results strengthened the government's commitment to further investment in assisted reproductive services and the Embryo Protection Authority.
He said that additional human and financial resources would be provided to the Authority, alongside new fertility education programmes and national awareness campaigns on reproductive health.
He said the government's approach had been based on investment in people, healthcare professionals and advanced technology, while also introducing legislative changes aimed at ensuring Malta's legal framework continued to reflect modern realities.
"The aim has always been to provide the necessary tools so that we can have the greatest possible number of success stories," Borg said.